Citigroup Maintains Buy on Teradyne, Raises Price Target to $500

Benzinga Newsdesk www.benzinga.com Positive 73.4%

Neg 0% Neu 0% Pos 73.4%

Citigroup analyst Timothy Arcuri maintains Teradyne (NASDAQ:TER) with a Buy and raises the price target from $440 to $500.